Investigating the Association of Vitamin D Metabolism Genes CYP2R1, CYP24A1 and CYP27B1 with Vitamin D Status in Young Adult Emiratis

Fatme Al Anouti¹, Sarah El Hajj Chehadeh², Enas Osman², Gehad ElGhazali³ and Habiba Al Safar^{2, 4,}

¹Zayed University, Abu Dhabi, United Arab Emirates

²Khalifa University Center of Biotechnology, Abu Dhabi, United Arab emirates

³Institute of Laboratory Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

⁴Khalifa University of Science, Technology & Research, Biomedical Department, Abu Dhabi, United Arab Emirates

Cite this paper:
Fatme Al Anouti, Sarah El Hajj Chehadeh, Enas Osman, Gehad ElGhazali and Habiba Al Safar. Investigating the Association of Vitamin D Metabolism Genes CYP2R1, CYP24A1 and CYP27B1 with Vitamin D Status in Young Adult Emiratis. Journal of Food and Nutrition Research. 2017; 5(1):15-21. doi: 10.12691/jfnr-5-1-3

Abstract

Despite the sunny weather in the Arabic Gulf Countries, vitamin D (VTD) insufficiency has been recently recognized as a serious health problem in this region. While diet and sun exposure are the main factors which determine the concentration of 25-hydroxyvitamin D₃ [25(OH)D₃], genetic variants VTD metabolizing enzymes, especially CYP2R1, CYP24A1 and CYP27B1, have gained a lot of interest lately. This study aims to investigate the association between VTD insufficiency and genetic variants of CYP2R1, CYP27B1 and CYP24A1 among young adult Emiratis. Healthy young adult United Arab Emirates (UAE) nationals (111 female, 52 male) with a mean age of 20.32 ± 2.35 years were recruited for the study. Genotyping for 5 single nucleotide polymorphisms (SNPs) in CYP2R1, CYP24A1 and CYP27B1 genes were performed by TaqMan^® assays, while serum 25(OH)D₃ was measured by Diasorin analyzer (LIAISON). Our results showed that the GT+TT genotype of CYP27B1 (rs10877012) (OR: 6.13, 95%CI [1.76-21.33], p=0.001) and the AG+GG genotype of CYP27B1 (rs4646536) (OR: 2.57, 95%CI [1.02-6.49], p=0.040) were significantly more frequent in VTD insufficient subjects while the GG genotype of CYP24A1 (rs2762939) (OR: 0.10, 95%CI [0.006-1.81], p=0.036) and the TT genotype of CYP24A1 (rs6013897) (OR: 0.10, 95%CI [0.006-1.76], p=0.033) were significantly more frequent in sufficient subjects. Moreover, the haplotype (GTGA) was significantly more frequent in sufficient subjects (p=1.22x10^-5), while the frequency of haplotype GTTG was significantly high in the insufficient group (p=0.004). The data strongly suggest that genetic variants relevant to VTD metabolism could play an important role in defining VTD status among the young adult Emirati population.

Keywords:
Vitamin D metabolism CYP2R1 CYP24A1 and CYP27B1 Genetic variants Emiratis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, et al. (2006). Vitamin D deficiency: a global perspective. Arquivos Brasileiros de Endocrinologia & Metabologia 50: 640-646.
[2]	Gordon NP, Caan BJ, Asgari MM (2012). Variation in vitamin D supplementation among adults in a multi-race/ethnic health plan population, 2008. Nutrition journal 11: 1.
[3]	Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, et al. (2011). Vitamin D, cardiovascular disease and mortality. Clinical endocrinology 75: 575-584.
[4]	Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, et al. (2011). Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer 128: 1414-1424.
[5]	Weinstock-Guttman B, Mehta BK, Ramanathan M, Karmon Y, Henson LJ, et al. (2012). Vitamin D and multiple sclerosis. The neurologist 18: 179-183.
[6]	Dawodu A, Absood G, Patel M, Agarwal M, Ezimokhai M, et al. (1998). Biosocial factors affecting vitamin D status of women of childbearing age in the United Arab Emirates. Journal of biosocial science 30: 431-437.
[7]	Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, et al. (2014). Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism 99: E2133-E2137.
[8]	Sakaki T, Kagawa N, Yamamoto K, Inouye K (2005). Metabolism of vitamin D3 by cytochromes P450. Front Biosci 10.
[9]	Badawi A, Arora P, Sadoun E, Al-Thani A-A, Al Thani MH (2012). Prevalence of vitamin D insufficiency in Qatar: a systematic review. Journal of public health research 1: 229-235.
[10]	Al-Anouti F, Al-Ameri S, Thomas J, Abdel-Wareth L, Devkaran S, et al. (2013). Sun avoidance among indoor employees leading to vitamin D deficiency and depression in the United Arab Emirates. International Journal of Medicine and Medical Sciences 5: 503-509.
[11]	Abdelgadir EIE, Bashier AM, Kathamuthu R, Bashiri S, Alawadi F (2013) Vitamin D Deficiency and Insufficiency in Patients Attending a General Hospital in Dubai, United Arab Emirates. Ibnosina Journal of Medicine and Biomedical Sciences 6: 81-84.
[12]	Muhairi SJ, Mehairi AE, Khouri AA, Naqbi MM, Maskari FA, et al. (2013). Vitamin D deficiency among healthy adolescents in Al Ain, United Arab Emirates. BMC Public Health 13: 1.
[13]	Al Anouti F, Thomas J, Abdel-Wareth L, Rajah J, Grant WB, et al. (2011). Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates. Dermato-endocrinology 3: 235-239.
[14]	Autier P, Gandini S (2007). Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of internal medicine 167: 1730-1737.
[15]	Ross A, Taylor C, Yaktine A, Del Valle H (2011). Dietary reference intakes for vitamin D and calcium. Food and nutrition 4th ed Washington DC: The national academies press.
[16]	(January 2015). World Health Organisation. Obesity and overweight http://wwwwhoint/mediacentre/factsheets/fs311/en/.
[17]	Ersfeld DL, Rao DS, Body J-J, Sackrison JL, Miller AB, et al. (2004). Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer. Clinical biochemistry 37: 867-874.
[18]	Osman E, Al Anouti F, Haq A, Mirgani R, Al Safar H (2015). Frequency of rs731236 (Taql), rs2228570 (Fok1) of Vitamin-D Receptor (VDR) gene in Emirati healthy population. Meta gene 6: 49-52.
[19]	Gilbert R, Bonilla C, Metcalfe C, Lewis S, Evans DM, et al. (2015). Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1, 25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study. Cancer Causes & Control 26: 205-218.
[20]	Hibler EA, Klimentidis YC, Jurutka PW, Kohler LN, Lance P, et al. (2015). CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutrition and cancer 67: 1131-1141.
[21]	Muindi JR, Adjei AA, Wu ZR, Olson I, Huang H, et al. (2013). Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes. Hormones and Cancer 4: 242-250.
[22]	Cooper JD, Smyth DJ, Walker NM, Stevens H, Burren OS, et al. (2011). Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 60: 1624-1631.
[23]	McGrath JJ, Saha S, Burne TH, Eyles DW (2010). A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. The Journal of steroid biochemistry and molecular biology 121: 471-477.
[24]	Orton S-M, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al. (2008). Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. The American journal of clinical nutrition 88: 441-447.
[25]	Kong J, Xu F, Qu J, Wang Y, Gao M, et al. (2015). Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival. Oncotarget 6: 2573-2582.
[26]	Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, et al. (2005). Altered pharmacokinetics of 1α, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 146: 825-834.
[27]	Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW (2003). De-orphanization of Cytochrome P450 2R1 a microsomal vitamin D 25-hydroxylase. Journal of Biological Chemistry 278: 38084-38093.
[28]	Bu F-X, Armas L, Lappe J, Zhou Y, Gao G, et al. (2010). Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Human genetics 128: 549-556.
[29]	Veldurthy V, Wei R, Campbell M, Lupicki K, Dhawan P, et al. (2016). 25-Hydroxyvitamin D 3 24-Hydroxylase: A Key Regulator of 1, 25 (OH) 2 D 3 Catabolism and Calcium Homeostasis. Vitamins & Hormones 100: 137-150.
[30]	Kuroda M, Sakaue H (2016). [Role of vitamin D and calcium in obesity and type 2 diabetes]. Clin Calcium 26: 349-354.
[31]	Lu L, Gan W, Zhu J, Tang H, Li H, et al. (2012). Associations between common variants in CYP24A1 and risk of obesity in Chinese Hans. The FASEB Journal 26: 386.381.
[32]	Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, et al. (2011). Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. Journal of hepatology 54: 887-893.
[33]	Bailey R, Cooper JD, Zeitels L, Smyth DJ, Yang JH, et al. (2007). Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56: 2616-2621.